ListarNeurología por tema "Teriflunomide"

Mostrando ítems 1-2 de 2

Baseline Characteristics of Patients with Relapsing Multiple Sclerosis in ASCLEPIOS Phase 3 Trials of Ofatumumab Versus Teriflunomide (P3.2-096)

Kappos, Ludwig; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Leppert, David; Kerloeguen, Cecile; Willi, Roman; Häring, Dieter A.; Tomic, Davorka; Goodyear, Alexandra; Merschhemke, Martin; Hauser, Stephen L. (Lippincott Williams & Wilkins, 2019-04-16)

Objective: To present the baseline characteristics of patients enrolled in the ASCLEPIOS I and II trials. Background: ASCLEPIOS I and II are two Phase 3 trials of identical design that are being conducted simultaneously ...
Palmar pustular psoriasis associated with teriflunomide treatment

Negrotto, Laura; Correale, Jorge (Elsevier, 2019-01)

Background Cutaneous adverse effects of Teriflunomide have been rarely reported. Objective and methods We report a relapsing remitting multiple sclerosis patient that developed palmar pustular psoriasis within one ...

Buscar en DSpace